Ingevity Key Executives

This section highlights Ingevity's key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at Ingevity

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

Ingevity Earnings

This section highlights Ingevity's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: May 07, 2025
Time: Before Market
Est. EPS: $-
Status: Unconfirmed

Last Earnings Results

Date: February 18, 2025
EPS: $0.95
Est. EPS: $0.29
Revenue: $298.80M

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-19 N/A N/A
Read Transcript Q3 2024 2024-10-30 N/A N/A
Read Transcript Q2 2024 2024-08-02 N/A N/A
Read Transcript Q1 2024 2024-05-02 N/A N/A
Read Transcript Q4 2023 2024-02-22 N/A N/A
Read Transcript Q3 2023 2023-11-04 N/A N/A
Read Transcript Q2 2023 2023-08-05 N/A N/A
Read Transcript Q1 2023 2023-05-06 N/A N/A

Ingevity Corporation (NGVT)

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Basic Materials Chemicals - Specialty

$40.32

Stock Price

$1.47B

Market Cap

1.60K

Employees

North Charleston, SC

Location

Financial Statements

Access annual & quarterly financial statements for Ingevity, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $1.41B $1.69B $1.67B $1.39B $1.22B
Cost of Revenue $951.70M $1.22B $1.10B $878.70M $750.60M
Gross Profit $454.70M $471.90M $570.10M $512.80M $465.50M
Gross Profit Ratio 32.33% 27.90% 34.17% 36.90% 38.28%
Research and Development Expenses $- $31.80M $30.30M $26.30M $22.60M
General and Administrative Expenses $- $- $- $- $-
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $166.70M $141.80M $198.80M $179.30M $149.40M
Other Expenses $- $- $1.70M $-79.90M $4.10M
Operating Expenses $166.70M $183.70M $229.10M $205.60M $172.00M
Cost and Expenses $1.12B $1.39B $1.33B $1.08B $922.60M
Interest Income $6.90M $6.30M $7.50M $4.40M $4.90M
Interest Expense $97.80M $93.30M $54.30M $47.70M $42.20M
Depreciation and Amortization $108.30M $122.80M $124.90M $127.20M $118.20M
EBITDA $-329.50M $224.60M $456.30M $337.20M $397.80M
EBITDA Ratio -23.43% 13.27% 27.06% 24.23% 32.71%
Operating Income $288.00M $288.20M $342.70M $227.30M $297.60M
Operating Income Ratio 20.48% 17.03% 20.54% 16.33% 24.47%
Total Other Income Expenses Net $-823.60M $-298.30M $-71.40M $-144.40M $-58.40M
Income Before Tax $-535.60M $-10.10M $269.60M $162.80M $235.10M
Income Before Tax Ratio -38.08% -0.60% 16.16% 11.70% 19.33%
Income Tax Expense $-105.30M $-4.70M $58.00M $44.70M $48.90M
Net Income $-430.30M $-5.40M $211.60M $118.10M $181.40M
Net Income Ratio -30.60% -0.32% 12.68% 8.49% 14.92%
EPS $-11.85 $-0.15 $5.54 $2.97 $4.39
EPS Diluted $-11.85 $-0.15 $5.50 $2.95 $4.37
Weighted Average Shares Outstanding 36.30M 36.50M 38.18M 39.82M 41.33M
Weighted Average Shares Outstanding Diluted 36.30M 36.50M 38.47M 40.06M 41.55M
SEC Filing Source Source Source Source Source


Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $298.80M $376.90M $390.60M $340.10M $371.70M $446.00M $481.80M $392.60M $383.60M $482.00M $419.90M $382.80M $336.00M $376.80M $358.40M $320.30M $325.60M $331.70M $270.60M $288.20M
Cost of Revenue $196.90M $247.00M $275.70M $250.60M $312.20M $317.00M $328.80M $262.20M $278.20M $305.70M $269.30M $245.00M $231.00M $235.00M $218.60M $194.10M $198.20M $192.10M $186.70M $173.60M
Gross Profit $101.90M $129.90M $114.90M $89.50M $59.50M $129.00M $153.00M $130.40M $105.40M $176.30M $150.60M $137.80M $105.00M $141.80M $139.80M $126.20M $127.40M $139.60M $83.90M $114.60M
Gross Profit Ratio 34.10% 34.50% 29.40% 26.30% 16.00% 28.90% 31.80% 33.20% 27.50% 36.60% 35.90% 36.00% 31.30% 37.60% 39.00% 39.40% 39.13% 42.09% 31.01% 39.76%
Research and Development Expenses $- $6.70M $7.30M $6.80M $7.20M $7.80M $8.00M $8.80M $7.20M $7.60M $8.20M $7.30M $7.00M $6.80M $5.90M $6.60M $5.80M $5.20M $5.40M $6.20M
General and Administrative Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $38.50M $- $- $38.50M
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $3.00M $- $- $-
Selling General and Administrative Expenses $39.40M $38.70M $33.90M $37.70M $43.40M $40.00M $51.70M $48.60M $55.90M $54.20M $48.70M $40.00M $48.30M $43.50M $47.50M $40.00M $41.50M $34.90M $34.50M $38.50M
Other Expenses $- $84.50M $-2.90M $- $-36.20M $-1.30M $-3.00M $18.20M $700.00K $-2.00M $1.60M $-1.90M $1.70M $600.00K $4.20M $-1.20M $4.00M $-1.70M $-900.00K $-2.00M
Operating Expenses $39.40M $129.90M $41.20M $44.50M $43.40M $47.80M $59.70M $57.40M $63.10M $61.80M $56.90M $47.30M $55.30M $50.30M $53.40M $46.60M $47.30M $40.10M $39.90M $44.70M
Cost and Expenses $236.30M $291.60M $316.90M $295.10M $355.60M $364.80M $388.50M $319.60M $341.30M $367.50M $326.20M $292.30M $286.30M $285.30M $272.00M $240.70M $245.50M $232.20M $226.60M $218.30M
Interest Income $4.30M $700.00K $900.00K $1.00M $3.40M $700.00K $1.20M $1.00M $300.00K $1.30M $3.70M $2.20M $1.90M $1.00M $900.00K $600.00K $1.40M $800.00K $1.20M $1.50M
Interest Expense $25.50M $24.50M $24.10M $23.30M $22.70M $23.10M $21.60M $19.60M $17.00M $11.50M $15.10M $12.90M $11.50M $12.60M $12.20M $12.40M $12.40M $9.70M $11.20M $10.90M
Depreciation and Amortization $25.20M $26.20M $27.30M $29.60M $25.10M $40.10M $36.00M $35.40M $32.80M $30.00M $30.40M $31.70M $32.60M $31.80M $31.40M $31.40M $26.70M $25.10M $24.10M $24.30M
EBITDA $59.50M $-87.20M $-283.20M $-19.00M $-102.80M $116.40M $123.70M $122.30M $-41.60M $138.20M $125.70M $117.90M $-32.40M $35.40M $118.20M $106.10M $110.60M $124.60M $68.10M $94.20M
EBITDA Ratio 19.91% -23.14% 25.86% 21.93% 4.33% 25.81% 25.26% 31.15% 19.08% 28.67% 28.84% 30.80% 23.69% 32.03% 32.84% 32.91% 25.83% 37.29% 25.28% 31.99%
Operating Income $62.50M $84.50M $73.70M $45.00M $16.10M $89.00M $101.30M $91.20M $43.00M $112.50M $95.30M $90.80M $49.70M $91.50M $86.40M $79.60M $80.10M $99.50M $44.00M $69.90M
Operating Income Ratio 20.92% 22.42% 18.87% 13.23% 4.33% 19.96% 21.03% 23.23% 11.21% 23.34% 22.70% 23.72% 14.79% 24.28% 24.11% 24.85% 24.60% 30.00% 16.26% 24.25%
Total Other Income Expenses Net $-53.70M $-222.40M $-409.10M $-117.60M $-162.90M $-49.10M $-45.60M $-8.90M $-22.60M $-18.70M $-17.20M $-12.90M $-13.40M $-100.50M $-12.70M $-17.80M $-13.70M $-11.40M $-18.60M $-14.70M
Income Before Tax $8.80M $-137.90M $-334.60M $-71.90M $-154.00M $32.10M $47.70M $64.10M $19.70M $95.80M $76.50M $77.60M $36.30M $-9.00M $73.70M $61.80M $66.40M $88.10M $25.40M $55.20M
Income Before Tax Ratio 2.95% -36.59% -85.66% -21.14% -41.43% 7.20% 9.90% 16.33% 5.14% 19.88% 18.22% 20.27% 10.80% -2.39% 20.56% 19.29% 20.39% 26.56% 9.39% 19.15%
Income Tax Expense $-7.80M $-30.70M $-50.90M $-15.90M $-37.20M $6.90M $12.20M $13.40M $4.10M $20.40M $16.70M $16.80M $7.00M $-4.80M $29.40M $13.10M $15.60M $18.20M $5.20M $9.90M
Net Income $16.60M $-107.20M $-283.70M $-56.00M $-116.80M $25.20M $35.50M $50.70M $15.60M $75.40M $59.80M $60.80M $29.30M $-4.20M $44.30M $48.70M $46.00M $69.90M $20.20M $45.30M
Net Income Ratio 5.56% -28.44% -72.63% -16.47% -31.42% 5.65% 7.37% 12.91% 4.07% 15.64% 14.24% 15.88% 8.72% -1.11% 12.36% 15.20% 14.13% 21.07% 7.46% 15.72%
EPS $0.46 $-2.95 $-7.81 $-1.54 $-3.23 $0.70 $0.98 $1.36 $0.42 $1.99 $1.55 $1.56 $0.74 $-0.11 $1.11 $1.21 $1.24 $1.69 $0.49 $1.09
EPS Diluted $0.45 $-2.95 $-7.81 $-1.54 $-3.23 $0.69 $0.97 $1.35 $0.41 $1.98 $1.54 $1.55 $0.74 $-0.11 $1.10 $1.20 $1.23 $1.69 $0.49 $1.08
Weighted Average Shares Outstanding 36.30M 36.30M 36.34M 36.26M 36.20M 36.23M 36.37M 37.17M 37.40M 37.84M 38.52M 39.01M 39.30M 38.18M 40.00M 40.40M 41.10M 41.28M 41.23M 41.70M
Weighted Average Shares Outstanding Diluted 36.60M 36.30M 36.34M 36.26M 36.20M 36.39M 36.60M 37.55M 37.70M 38.13M 38.75M 39.26M 39.60M 39.54M 40.30M 40.70M 41.40M 41.45M 41.37M 42.00M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $68.00M $95.90M $76.70M $275.40M $257.70M
Short Term Investments $- $- $- $- $200.00K
Cash and Short Term Investments $68.00M $95.90M $76.70M $275.40M $257.70M
Net Receivables $141.00M $211.00M $249.30M $167.00M $166.70M
Inventory $226.80M $308.80M $335.00M $241.20M $189.00M
Other Current Assets $- $42.30M $22.30M $41.30M $15.30M
Total Current Assets $435.80M $658.60M $679.00M $724.90M $628.70M
Property Plant Equipment Net $709.30M $829.40M $798.60M $719.70M $703.60M
Goodwill $175.20M $527.50M $518.50M $442.00M $445.30M
Intangible Assets $278.80M $385.30M $404.80M $337.60M $373.30M
Goodwill and Intangible Assets $454.00M $912.80M $923.30M $779.60M $818.60M
Long Term Investments $87.30M $99.20M $109.80M $35.30M $-8.10M
Tax Assets $117.90M $11.60M $5.70M $6.80M $8.10M
Other Non-Current Assets $- $111.70M $220.10M $202.70M $183.60M
Total Non-Current Assets $1.37B $1.96B $2.06B $1.74B $1.71B
Other Assets $218.30M $- $- $- $-
Total Assets $2.02B $2.62B $2.74B $2.47B $2.33B
Account Payables $94.50M $158.40M $174.80M $125.80M $104.20M
Short Term Debt $78.20M $102.00M $33.90M $54.40M $58.40M
Tax Payables $5.60M $9.20M $8.90M $14.40M $11.50M
Deferred Revenue $10.50M $67.50M $6.80M $14.70M $4.40M
Other Current Liabilities $75.30M $93.30M $85.90M $74.30M $49.30M
Total Current Liabilities $264.10M $362.90M $303.50M $268.90M $223.40M
Long Term Debt $1.38B $1.43B $1.51B $1.18B $1.20B
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $56.20M $70.90M $106.50M $114.60M $111.80M
Other Non-Current Liabilities $130.60M $126.70M $114.90M $227.10M $152.20M
Total Non-Current Liabilities $1.56B $1.63B $1.73B $1.53B $1.46B
Other Liabilities $- $- $- $- $-
Total Liabilities $1.83B $1.99B $2.04B $1.80B $1.69B
Preferred Stock $- $- $- $- $-
Common Stock $400.00K $400.00K $400.00K $400.00K $400.00K
Retained Earnings $572.00M $1.00B $1.01B $796.10M $678.00M
Accumulated Other Comprehensive Income Loss $-41.40M $-26.70M $-46.80M $13.10M $4.70M
Other Total Stockholders Equity $-335.80M $-344.60M $-263.00M $-135.80M $-41.00M
Total Stockholders Equity $195.20M $631.40M $698.30M $673.80M $647.30M
Total Equity $195.20M $631.40M $698.30M $673.80M $647.30M
Total Liabilities and Stockholders Equity $2.02B $2.62B $2.74B $2.47B $2.33B
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $2.02B $2.62B $2.74B $2.47B $2.33B
Total Investments $87.30M $99.20M $109.80M $35.30M $-8.10M
Total Debt $1.45B $1.53B $1.49B $1.25B $1.27B
Net Debt $1.39B $1.44B $1.41B $974.60M $1.01B


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $68.00M $135.50M $125.30M $105.10M $96.50M $84.50M $68.00M $77.90M $76.70M $72.30M $131.30M $222.60M $275.40M $269.40M $233.30M $237.80M $257.70M $198.20M $177.60M $302.70M
Short Term Investments $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $100.00K $100.00K $100.00K
Cash and Short Term Investments $68.00M $135.50M $125.30M $105.10M $96.50M $84.50M $68.00M $77.90M $76.70M $72.30M $131.30M $222.60M $275.40M $269.40M $233.30M $237.80M $257.70M $198.20M $177.60M $302.70M
Net Receivables $141.00M $189.90M $213.40M $207.20M $211.00M $216.60M $259.70M $240.40M $249.30M $248.40M $221.40M $206.90M $167.00M $175.80M $177.30M $168.40M $166.70M $154.30M $132.10M $147.70M
Inventory $226.80M $261.00M $302.00M $325.50M $309.80M $386.70M $387.10M $361.40M $335.00M $281.80M $277.00M $260.20M $241.20M $228.30M $214.50M $204.20M $189.00M $204.00M $223.50M $236.20M
Other Current Assets $- $50.40M $63.00M $48.00M $42.90M $46.70M $49.60M $36.60M $22.30M $42.60M $48.00M $43.10M $41.30M $46.80M $44.50M $32.00M $15.30M $44.50M $46.50M $37.90M
Total Current Assets $435.80M $636.80M $685.80M $669.20M $658.60M $734.50M $764.40M $716.30M $679.00M $645.10M $677.70M $732.80M $724.90M $720.30M $669.60M $642.40M $628.70M $601.00M $579.70M $724.50M
Property Plant Equipment Net $658.90M $727.30M $782.50M $790.10M $829.40M $800.00M $800.60M $804.60M $798.60M $720.70M $717.40M $769.60M $719.70M $751.90M $699.50M $697.90M $703.60M $737.40M $707.50M $659.70M
Goodwill $175.20M $186.90M $177.00M $525.90M $527.50M $520.10M $527.10M $522.00M $518.50M $387.60M $410.80M $433.10M $442.00M $440.70M $449.00M $447.70M $445.30M $427.80M $415.70M $416.80M
Intangible Assets $278.80M $298.60M $295.70M $302.80M $385.30M $375.60M $394.20M $398.70M $404.80M $272.20M $297.30M $322.30M $337.60M $344.80M $359.70M $367.10M $373.30M $366.50M $363.70M $370.30M
Goodwill and Intangible Assets $454.00M $485.50M $472.70M $828.70M $912.80M $895.70M $921.30M $920.70M $923.30M $659.80M $708.10M $755.40M $779.60M $785.50M $808.70M $814.80M $818.60M $794.30M $779.40M $787.10M
Long Term Investments $87.30M $87.30M $174.40M $173.90M $178.30M $99.30M $99.40M $98.90M $109.80M $77.50M $77.10M $76.60M $35.30M $75.50M $-7.50M $-7.90M $-8.10M $1.00M $7.80M $-5.00M
Tax Assets $- $113.90M $80.70M $23.80M $11.60M $105.00M $109.50M $7.40M $5.70M $6.90M $9.30M $6.90M $6.80M $6.90M $7.50M $7.90M $8.10M $6.20M $5.60M $5.00M
Other Non-Current Assets $- $160.80M $80.10M $81.20M $32.60M $132.30M $133.10M $224.30M $220.10M $225.40M $176.40M $114.50M $202.70M $86.10M $211.20M $187.40M $183.60M $118.30M $115.50M $182.00M
Total Non-Current Assets $1.20B $1.57B $1.59B $1.90B $1.96B $2.03B $2.06B $2.06B $2.06B $1.69B $1.69B $1.72B $1.74B $1.71B $1.72B $1.70B $1.71B $1.66B $1.62B $1.63B
Other Assets $386.60M $- $1 $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $2.02B $2.21B $2.28B $2.57B $2.62B $2.77B $2.83B $2.77B $2.74B $2.34B $2.37B $2.46B $2.47B $2.43B $2.39B $2.34B $2.33B $2.26B $2.20B $2.35B
Account Payables $94.50M $96.50M $142.40M $153.10M $158.40M $197.30M $203.60M $173.90M $174.80M $164.60M $168.30M $128.90M $125.80M $127.40M $115.60M $113.50M $104.20M $84.80M $78.70M $105.00M
Short Term Debt $78.20M $137.10M $140.00M $122.30M $121.80M $39.80M $36.30M $33.50M $17.40M $33.70M $34.90M $354.00M $37.00M $52.30M $50.90M $50.50M $42.20M $55.60M $54.70M $55.40M
Tax Payables $10.50M $4.70M $2.70M $8.00M $9.20M $5.40M $5.10M $-13.40M $8.90M $6.80M $5.60M $9.80M $14.40M $3.60M $8.80M $15.20M $11.50M $3.10M $18.50M $18.50M
Deferred Revenue $10.50M $- $2.70M $8.00M $9.20M $-21.40M $45.10M $- $6.80M $- $9.30M $- $6.80M $3.60M $8.80M $9.10M $8.10M $3.10M $18.50M $-8.40M
Other Current Liabilities $70.40M $122.50M $72.70M $68.30M $73.50M $62.60M $66.10M $84.80M $102.40M $85.20M $58.40M $59.00M $91.70M $64.30M $57.50M $45.30M $65.50M $35.40M $36.00M $28.80M
Total Current Liabilities $264.10M $360.80M $357.80M $351.70M $362.90M $305.10M $311.10M $278.80M $303.50M $290.30M $267.20M $551.70M $268.90M $247.60M $232.80M $224.50M $223.40M $178.90M $187.90M $207.70M
Long Term Debt $1.38B $1.44B $1.44B $1.45B $1.43B $1.52B $1.57B $1.54B $1.51B $1.19B $1.21B $980.10M $1.29B $1.29B $1.29B $1.30B $1.22B $1.31B $1.34B $1.50B
Deferred Revenue Non-Current $- $- $-61.60M $45.00M $148.60M $-105.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $56.20M $65.70M $61.60M $64.40M $72.10M $105.00M $109.50M $107.50M $106.50M $106.60M $114.10M $116.10M $114.60M $116.30M $130.00M $118.80M $111.80M $109.50M $103.90M $104.30M
Other Non-Current Liabilities $130.60M $133.20M $129.10M $128.90M $125.50M $117.70M $118.90M $117.20M $114.10M $119.60M $119.60M $121.80M $125.50M $127.70M $45.20M $41.80M $134.70M $38.30M $39.20M $35.70M
Total Non-Current Liabilities $1.56B $1.64B $1.63B $1.65B $1.63B $1.74B $1.80B $1.77B $1.73B $1.41B $1.44B $1.22B $1.53B $1.53B $1.47B $1.46B $1.46B $1.46B $1.48B $1.64B
Other Liabilities $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $1.83B $2.00B $1.99B $2.00B $1.99B $2.05B $2.11B $2.05B $2.04B $1.70B $1.71B $1.77B $1.80B $1.78B $1.70B $1.68B $1.69B $1.64B $1.67B $1.85B
Preferred Stock $- $- $- $- $- $- $- $0 $- $- $- $- $- $- $- $- $5.20M $- $- $100.00K
Common Stock $- $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K $400.00K
Retained Earnings $- $555.40M $662.60M $946.30M $1.00B $1.12B $1.09B $1.06B $1.01B $992.10M $916.70M $856.90M $796.10M $766.80M $771.00M $726.70M $678.00M $632.00M $562.10M $541.90M
Accumulated Other Comprehensive Income Loss $- $-3.50M $-37.50M $-35.60M $-26.70M $-53.90M $-33.50M $-38.80M $-46.80M $-95.30M $-43.70M $3.00M $13.10M $7.50M $18.60M $13.20M $4.70M $-25.60M $-48.20M $-44.10M
Other Total Stockholders Equity $195.20M $-337.80M $-340.70M $-342.90M $-344.60M $-346.90M $-346.70M $-294.30M $-263.00M $-263.30M $-219.10M $-174.20M $-135.80M $-130.20M $-101.50M $-79.20M $-41.00M $10.20M $8.60M $3.90M
Total Stockholders Equity $195.20M $214.50M $284.80M $568.20M $631.40M $718.70M $714.10M $725.70M $698.30M $633.90M $654.30M $686.10M $673.80M $644.50M $688.50M $661.10M $647.30M $617.00M $522.90M $502.10M
Total Equity $195.20M $214.50M $284.80M $568.20M $631.40M $718.70M $714.10M $725.70M $698.30M $633.90M $654.30M $686.10M $673.80M $644.50M $688.50M $661.10M $647.30M $617.00M $522.90M $502.10M
Total Liabilities and Stockholders Equity $2.02B $2.21B $2.28B $2.57B $2.62B $2.77B $2.83B $2.77B $2.74B $2.34B $2.37B $2.46B $2.47B $2.43B $2.39B $2.34B $2.33B $2.26B $2.20B $2.35B
Minority Interest $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $2.02B $2.21B $2.28B $2.57B $2.62B $2.77B $2.83B $2.77B $2.74B $2.34B $2.37B $2.46B $2.47B $2.43B $2.39B $2.34B $2.33B $2.26B $2.20B $2.35B
Total Investments $87.30M $87.30M $174.40M $173.90M $178.30M $99.30M $99.40M $98.90M $109.80M $77.50M $77.10M $76.60M $35.30M $75.50M $-7.50M $-7.90M $-8.10M $1.10M $7.90M $-5.00M
Total Debt $1.45B $1.56B $1.56B $1.56B $1.53B $1.47B $1.53B $1.50B $1.49B $1.17B $1.19B $1.32B $1.25B $1.33B $1.26B $1.26B $1.27B $1.35B $1.38B $1.47B
Net Debt $1.39B $1.42B $1.44B $1.45B $1.44B $1.39B $1.46B $1.42B $1.41B $1.10B $1.06B $1.09B $974.60M $1.06B $1.03B $1.03B $1.01B $1.16B $1.20B $1.17B

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $-430.30M $-5.40M $211.60M $118.10M $186.20M
Depreciation and Amortization $108.30M $122.80M $108.80M $109.90M $100.20M
Deferred Income Tax $-121.40M $-44.70M $-5.00M $-4.60M $16.20M
Stock Based Compensation $11.90M $10.60M $16.10M $12.30M $8.40M
Change in Working Capital $-200.00K $-93.30M $-66.80M $21.60M $8.70M
Accounts Receivables $38.20M $42.70M $-42.10M $-13.80M $2.80M
Inventory $86.20M $-75.60M $-63.70M $-55.80M $26.20M
Accounts Payables $-63.40M $-14.60M $42.70M $14.80M $9.40M
Other Working Capital $-61.20M $-45.80M $-3.70M $76.40M $-29.70M
Other Non Cash Items $560.30M $215.10M $48.40M $35.70M $32.70M
Net Cash Provided by Operating Activities $128.60M $205.10M $313.10M $293.00M $352.40M
Investments in Property Plant and Equipment $-77.60M $-109.80M $-142.50M $-103.80M $-105.90M
Acquisitions Net $- $- $-344.50M $- $-
Purchases of Investments $-300.00K $-2.40M $-77.40M $-35.30M $-2.00M
Sales Maturities of Investments $- $31.50M $14.70M $- $-
Other Investing Activities $-1.60M $3.40M $-4.20M $-1.50M $-2.70M
Net Cash Used for Investing Activities $-79.50M $-77.30M $-553.90M $-140.60M $-110.60M
Debt Repayment $-67.10M $-7.30M $199.00M $-26.00M $48.40M
Common Stock Issued $- $- $- $- $-
Common Stock Repurchased $- $-92.10M $-145.20M $-109.40M $-88.00M
Dividends Paid $- $- $- $- $-
Other Financing Activities $-3.10M $-500.00K $-5.70M $2.30M $-10.60M
Net Cash Used Provided by Financing Activities $-70.20M $-99.90M $48.10M $-133.10M $-50.20M
Effect of Forex Changes on Cash $-4.20M $-300.00K $-6.00M $-1.70M $2.20M
Net Change in Cash $-25.30M $27.60M $-198.70M $17.60M $193.80M
Cash at End of Period $86.60M $111.90M $77.30M $276.00M $258.40M
Cash at Beginning of Period $111.90M $84.30M $276.00M $258.40M $64.60M
Operating Cash Flow $128.60M $205.10M $313.10M $293.00M $352.40M
Capital Expenditure $-77.60M $-109.80M $-142.50M $-103.80M $-105.90M
Free Cash Flow $51.00M $95.30M $170.60M $189.20M $246.50M

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $16.60M $-107.20M $-283.70M $-56.00M $-116.80M $25.20M $35.50M $50.70M $15.60M $75.40M $59.80M $60.80M $29.30M $-4.20M $44.30M $48.70M $50.80M $69.90M $20.20M $45.30M
Depreciation and Amortization $25.20M $26.20M $27.30M $29.60M $25.10M $35.20M $31.40M $31.10M $30.20M $25.70M $25.80M $27.10M $28.20M $27.60M $27.10M $27.00M $26.70M $25.10M $24.10M $24.30M
Deferred Income Tax $- $-32.40M $-60.20M $-18.40M $-42.40M $-6.90M $-12.20M $-900.00K $-2.80M $-1.60M $-2.00M $1.40M $-2.40M $-13.50M $11.90M $-600.00K $4.90M $4.80M $-400.00K $6.50M
Stock Based Compensation $- $3.10M $2.40M $4.30M $2.30M $-600.00K $4.90M $4.00M $5.00M $4.40M $3.70M $3.00M $2.50M $3.10M $4.20M $2.50M $4.10M $1.10M $2.40M $800.00K
Change in Working Capital $18.60M $-42.20M $-45.90M $-69.60M $-23.60M $12.40M $-59.70M $-91.80M $41.20M $-12.90M $-10.00M $-85.10M $6.20M $78.90M $-29.70M $-33.80M $62.60M $-13.00M $-19.60M $-21.30M
Accounts Receivables $45.20M $26.10M $-22.90M $-10.20M $36.60M $42.40M $-22.30M $-14.00M $56.30M $-33.60M $-18.70M $-46.10M $14.40M $1.00M $-8.40M $-20.80M $8.40M $-20.60M $7.30M $7.70M
Inventory $28.40M $45.10M $27.00M $-14.30M $42.50M $-23.40M $-46.60M $-48.10M $-400.00K $-10.60M $-22.30M $-30.40M $-16.60M $-14.40M $-9.10M $-15.70M $17.20M $22.60M $12.30M $-25.90M
Accounts Payables $200.00K $-49.00M $-9.60M $-3.80M $-35.20M $800.00K $1.00M $-800.00K $-5.50M $-900.00K $41.40M $7.70M $-5.50M $9.50M $2.40M $8.40M $40.00M $-3.50M $-27.10M $9.40M
Other Working Capital $-55.20M $-64.40M $-40.40M $-41.30M $-67.50M $-7.40M $8.20M $-28.90M $-9.20M $32.20M $-10.40M $-16.30M $13.90M $82.80M $-14.60M $-5.70M $-3.00M $-11.50M $-12.10M $-12.50M
Other Non Cash Items $4.10M $199.00M $452.30M $189.80M $200.00M $40.30M $52.00M $12.10M $9.00M $9.10M $13.20M $17.10M $12.20M $8.20M $8.00M $7.30M $4.20M $2.10M $22.20M $4.60M
Net Cash Provided by Operating Activities $64.50M $46.50M $29.70M $-12.10M $44.60M $106.90M $48.40M $5.20M $98.20M $100.10M $90.50M $24.30M $76.00M $100.10M $65.80M $51.10M $153.30M $90.00M $48.90M $60.20M
Investments in Property Plant and Equipment $-24.90M $-18.00M $-18.10M $-16.60M $-29.20M $-33.50M $-21.70M $-25.40M $-49.20M $-36.10M $-29.60M $-27.60M $-37.40M $-25.50M $-23.90M $-17.00M $-31.10M $-40.30M $-15.00M $-19.50M
Acquisitions Net $- $- $- $- $100.00K $-100.00K $- $- $-344.50M $- $- $- $- $- $- $- $- $- $- $-
Purchases of Investments $-300.00K $- $- $- $- $-2.40M $- $- $-14.60M $-60.80M $-2.00M $- $-18.80M $- $-16.50M $- $- $- $- $-
Sales Maturities of Investments $- $- $- $- $-19.30M $100.00K $- $31.40M $-14.70M $14.70M $- $- $- $- $- $- $- $- $- $-
Other Investing Activities $-2.80M $600.00K $300.00K $300.00K $8.20M $1.10M $-1.70M $-4.10M $13.80M $-3.90M $3.20M $-2.60M $-1.00M $-700.00K $-16.00M $-300.00K $-1.10M $-700.00K $-2.20M $-700.00K
Net Cash Used for Investing Activities $-28.00M $-17.40M $-17.80M $-16.30M $-21.00M $-34.80M $-23.40M $1.90M $-409.20M $-86.10M $-28.40M $-30.20M $-57.20M $-26.20M $-39.90M $-17.30M $-32.20M $-41.00M $-17.20M $-20.20M
Debt Repayment $-97.40M $-6.20M $10.50M $26.00M $-6.50M $-53.70M $22.80M $29.70M $318.50M $-23.00M $-98.40M $-4.90M $-4.70M $-4.90M $-5.00M $-11.40M $1.30M $-31.60M $-159.60M $238.30M
Common Stock Issued $- $- $- $- $-4.70M $700.00K $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock Repurchased $- $2.80M $-200.00K $-2.60M $92.40M $-300.00K $-58.70M $-33.40M $-6.00M $-49.30M $-49.50M $-40.40M $-9.10M $-32.20M $-28.70M $-39.40M $-55.60M $- $100.00K $-32.40M
Dividends Paid $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $-200.00K $-100.00K $-200.00K $-2.60M $-1 $400.00K $1.40M $-1.90M $500.00K $700.00K $900.00K $-1.00M $1.00M $900.00K $2.20M $-1.30M $-10.70M $500.00K $2.30M $-2.70M
Net Cash Used Provided by Financing Activities $-97.60M $-6.30M $10.30M $23.40M $-6.50M $-53.30M $-34.50M $-5.60M $313.00M $-71.60M $-147.00M $-46.30M $-12.80M $-36.70M $-31.50M $-52.10M $-65.00M $-31.10M $-157.30M $203.20M
Effect of Forex Changes on Cash $-5.80M $5.40M $-2.00M $-1.80M $2.70M $-2.30M $-300.00K $-400.00K $2.60M $-1.40M $-6.50M $-700.00K $100.00K $-1.20M $1.10M $-1.70M $1.90M $-3.10M $500.00K $2.90M
Net Change in Cash $-66.90M $28.20M $20.20M $8.60M $11.40M $16.50M $-9.80M $1.10M $4.60M $-59.00M $-91.40M $-52.90M $6.10M $36.00M $-4.50M $-20.00M $58.00M $14.80M $-125.10M $246.10M
Cash at End of Period $86.60M $153.50M $125.30M $105.10M $96.50M $85.10M $68.60M $78.40M $77.30M $72.80M $131.80M $223.20M $276.00M $269.90M $233.90M $238.40M $258.40M $200.40M $185.60M $310.70M
Cash at Beginning of Period $153.50M $125.30M $105.10M $96.50M $85.10M $68.60M $78.40M $77.30M $72.70M $131.80M $223.20M $276.10M $269.90M $233.90M $238.40M $258.40M $200.40M $185.60M $310.70M $64.60M
Operating Cash Flow $64.50M $46.50M $29.70M $-12.10M $44.60M $106.90M $48.40M $5.20M $98.20M $100.10M $90.50M $24.30M $76.00M $100.10M $65.80M $51.10M $153.30M $90.00M $48.90M $60.20M
Capital Expenditure $-24.90M $-18.00M $-18.10M $-16.60M $-29.20M $-33.50M $-21.70M $-25.40M $-49.20M $-36.10M $-29.60M $-27.60M $-37.40M $-25.50M $-23.90M $-17.00M $-31.10M $-40.30M $-15.00M $-19.50M
Free Cash Flow $39.60M $28.50M $11.60M $-28.70M $15.40M $73.40M $26.70M $-20.20M $49.00M $64.00M $60.90M $-3.30M $38.60M $74.60M $41.90M $34.10M $122.20M $49.70M $33.90M $40.70M

Ingevity Dividends

Explore Ingevity's dividend history, including dividend yield, payout ratio, and historical payments.

Ingevity does not currently pay a dividend.

Ingevity News

Read the latest news about Ingevity, including recent articles, headlines, and updates.

Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?

NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

News image

Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting.

News image

Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

News image

Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

News image

Ingevity announces appointment of David H. Li as president and CEO

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025.

News image

Here's What Makes Ingevity Stock a Solid Choice Right Now

NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.

News image

Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International

Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article.

News image

5 Stocks With Upgraded Broker Ratings Worth Betting on Now

Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL.

News image

3 Chemical Specialty Stocks to Watch Amid Industry Challenges

Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and FSI are set to gain from strategic actions to navigate the ongoing challenges.

News image

Ingevity Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners (“Vision One”) earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking aggressive actions to deliver significant, sustainable value creation for all Ingevity stockholders. Over the last year, we have undertaken a broad range of initiative.

News image

Ingevity's Q4 Earnings Beat Estimates, Revenues Down Y/Y

NGVT's top line declines year over year in the fourth quarter due to the repositioning of the Performance Chemicals segment.

News image

Ingevity Corporation (NGVT) Q4 2024 Earnings Call Transcript

Ingevity Corporation (NYSE:NGVT ) Q4 2024 Earnings Conference Call February 19, 2025 10:00 AM ET Company Participants John Nypaver - Vice President, Treasurer and Investor Relations Luis Fernandez-Moreno - Interim President and Chief Executive Officer Mary Dean Hall - Executive Vice President and Chief Financial Officer Jonathan MacIver - Vice President of Global Commercial, Performance Materials Conference Call Participants Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies John McNulty - BMO Capital Markets Abigail Eberts - Wells Fargo Securities Operator Good morning or good afternoon all and welcome to the Ingevity Fourth Quarter and Full Year 2024 Earnings Call and Webcast. My name is Adam and I'll be your operator today.

News image

Ingevity reports fourth quarter and full year 2024 financial results

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation today reported its financial results for the fourth quarter and full year 2024.

News image

Time to Buy These 5 Value Stocks With High Earnings Yield

Unlock your portfolio value with high earnings yield stocks like DAN, NGVT, BVN, NE and SUZ.

News image

Is Ingevity (NGVT) Outperforming Other Basic Materials Stocks This Year?

Here is how Ingevity (NGVT) and Nouveau Monde Graphite Inc. (NMG) have performed compared to their sector so far this year.

News image

4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency

Unlock your portfolio value with high earnings yield value stocks like HRMY, NGVT, GPOR and PBI.

News image

Ingevity named as one of America's Most Responsible Companies of 2025 by Newsweek

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced it has been named as one of “America's Most Responsible Companies of 2025” by Newsweek magazine for the third consecutive year.

News image

Best Value Stocks to Buy for January 21st

NGVT, ICL and ADNT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2025.

News image

NGVT to Evaluate Strategic Alternatives for Industrial Specialties

Ingevity plans to review strategic alternatives for the Performance Chemicals Industrial Specialties product line to increase its shareholder value.

News image

Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity explores strategic alternatives for Industrial Specialties product line and CTO refinery; releases preliminary 2024 financial results.

News image

Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast.

News image

Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?

NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.

News image

Is Ingevity (NGVT) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

News image

Ingevity elects Kevin Willis to its board of directors

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Accomplished chemical industry CFO brings substantial finance, capital management expertise and experience driving corporate transformation.

News image

Here's Why You Should Add Ingevity Stock to Your Portfolio

NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.

News image

Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix

Axalta Coating Systems, Ingevity and AdvanSix have been highlighted in this Industry Outlook article.

News image

Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

News image

Should Value Investors Buy Ingevity (NGVT) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

News image

Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript

Ingevity Corporation (NYSE:NGVT ) Q3 2024 Earnings Call October 30, 2024 10:00 AM ET Company Participants John Nypaver - Investor Relations Luis Fernandez-Moreno - Interim Chief Executive Officer Mary Dean Hall - Chief Financial Officer Ed Woodcock - President, Performance Materials Rich White - President, Performance Chemicals Steve Hulme - President, Advanced Polymer Technologies Conference Call Participants Lee Jagoda - CJS Securities Daniel Rizzo - Jefferies John McNulty - BMO Capital Markets Mike Sison - Wells Fargo Operator Good morning or good afternoon, and welcome to the Ingevity Third Quarter 2024 Earnings Call and Webcast. My name is Adam, and I'll be your operator today.

News image

Similar Companies

E
Ecovyst Inc.

ECVT

Price: $6.46

Market Cap: $757.60M

E
Element Solutions Inc

ESI

Price: $23.74

Market Cap: $5.75B

F
H.B. Fuller Company

FUL

Price: $56.38

Market Cap: $3.05B

H
Hawkins, Inc.

HWKN

Price: $105.82

Market Cap: $2.21B

I
Innospec Inc.

IOSP

Price: $97.06

Market Cap: $2.42B

K
Quaker Chemical Corporation

KWR

Price: $128.53

Market Cap: $2.27B

M
Minerals Technologies Inc.

MTX

Price: $64.72

Market Cap: $2.06B

O
Oil-Dri Corporation of America

ODC

Price: $45.69

Market Cap: $617.85M

O
Orion Engineered Carbons S.A.

OEC

Price: $13.42

Market Cap: $760.30M

S
Sensient Technologies Corporation

SXT

Price: $73.15

Market Cap: $3.10B

Related Metrics

Explore detailed financial metrics and analysis for NGVT.